| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,726 |
19,725 |
$738K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,990 |
12,238 |
$620K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,773 |
5,627 |
$449K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,853 |
5,816 |
$445K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,448 |
4,412 |
$322K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,626 |
7,325 |
$322K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,011 |
6,746 |
$187K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,507 |
2,466 |
$173K |
| 96156 |
|
3,020 |
3,002 |
$120K |
| 99429 |
|
3,636 |
3,588 |
$106K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,176 |
3,102 |
$73K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,573 |
2,816 |
$69K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,976 |
4,852 |
$68K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
7,615 |
3,548 |
$60K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
701 |
698 |
$56K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,465 |
6,403 |
$54K |
| 99381 |
|
515 |
505 |
$38K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
434 |
433 |
$32K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,016 |
3,068 |
$30K |
| 99000 |
|
2,766 |
2,682 |
$25K |
| 99383 |
|
287 |
286 |
$23K |
| 99384 |
|
183 |
182 |
$17K |
| 0071A |
|
325 |
312 |
$13K |
| 83655 |
|
961 |
957 |
$10K |
| 99382 |
|
105 |
104 |
$8K |
| 90461 |
|
1,582 |
1,295 |
$5K |
| 0001A |
|
98 |
90 |
$4K |
| 96160 |
|
1,049 |
1,045 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
233 |
231 |
$1K |
| 90473 |
|
510 |
510 |
$1K |
| 90474 |
|
112 |
112 |
$1K |
| 82570 |
|
165 |
159 |
$622.02 |
| 85018 |
|
825 |
817 |
$595.84 |
| 0111A |
|
12 |
12 |
$480.00 |
| 81003 |
|
184 |
174 |
$255.46 |
| 92587 |
|
12 |
12 |
$151.02 |
| 90688 |
|
5,354 |
5,321 |
$148.96 |
| 90633 |
|
1,686 |
1,672 |
$74.75 |
| 84030 |
|
14 |
14 |
$71.82 |
| 90707 |
|
1,791 |
1,778 |
$44.85 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$31.77 |
| 90670 |
|
2,629 |
2,605 |
$29.90 |
| 90716 |
|
1,799 |
1,786 |
$29.90 |
| 90715 |
|
1,160 |
1,155 |
$14.96 |
| 90713 |
|
741 |
733 |
$14.95 |
| 90746 |
|
35 |
35 |
$14.95 |
| 90723 |
|
782 |
779 |
$14.95 |
| 90620 |
|
1,590 |
1,582 |
$14.95 |
| 90680 |
|
1,457 |
1,448 |
$14.95 |
| 91307 |
|
355 |
338 |
$0.22 |
| 90697 |
|
533 |
529 |
$0.19 |
| 90380 |
|
25 |
25 |
$0.02 |
| 90734 |
|
2,060 |
2,044 |
$0.01 |
| 90651 |
|
2,296 |
2,283 |
$0.01 |
| 90700 |
|
1,537 |
1,517 |
$0.00 |
| 90687 |
|
360 |
357 |
$0.00 |
| 90681 |
|
14 |
14 |
$0.00 |
| 91300 |
|
104 |
93 |
$0.00 |
| 91311 |
|
12 |
12 |
$0.00 |
| 90647 |
|
2,021 |
2,003 |
$0.00 |
| 90696 |
|
829 |
821 |
$0.00 |
| 96127 |
|
15 |
15 |
$0.00 |
| 99495 |
|
32 |
32 |
$0.00 |